Register to leave comments

  • News bot March 13, 2026, 12:06 p.m.

    📋 BARINTHUS BIOTHERAPEUTICS PLC (BRNS) - Financial Results

    Filing Date: 2026-03-13

    Accepted: 2026-03-13 08:03:44

    Event Type: Financial Results

    Event Details:

    BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Reports the reporting period Financial Results BARINTHUS BIOTHERAPEUTICS PLC (BRNS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 14969
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 70456
      • expected in the second half of 2026
      • targeting metabolic and autoimmune diseases, with four clinical data milestones expected within 18 months of the closing of the transaction.•In December 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Prepaid Expenses Other Current Assets 4.83K 6.20K $-1.37K -22.13%
    Property Equipment Net 3.52K 7.37K $-3.85K -52.22%
    Intangible Assets Net 14.29K 21.95K $-7.66K -34.90%
    Other Assets 930.00 881.00 $49.00 +5.56%
    Current Liabilities Accounts Payable 350.00 2.47K $-2.12K -85.85%
    Stockholders Equity Noncontrolling Interests 84.00 106.00 $-22.00 -20.75%
    Operating Expenses Loss From Operations -70.56K -67.97K $-2.58K -3.80%
    Other Incomeexpense Interest Income 1.96K 2.68K $-721.00 -26.92%
    Other Incomeexpense Interest Expense -51.00 -53.00 $2.00 +3.77%
    Other Incomeexpense Net Loss -66.46K -61.18K $-5.28K -8.62%
    Net Loss -66.46K -66.46K $0.00 +0.00%
    Loss from Operations -70.56K -67.97K $-2.58K -3.80%
    Interest Income 1.96K 2.68K $-721.00 -26.92%
    Interest Expense -51.00 -53.00 $2.00 +3.77%
    Other Income, Net 3.92K 6.74K $-2.82K -41.84%
    Net Loss -66.46K -61.18K $-5.28K -8.62%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BARINTHUS BIOTHERAPEUTICS PLC
    • Ticker Symbol: BRNS